Address
Email address
Phone number
Perearst Signe Alliksoo | Perearstikeskus | Estonia Vastuvötuajad
Name
Dr.Signe Alliksoo Perearstipraksis OÜ
Registry code
11197129
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.12.2005 (18)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Signe Alliksoo 14.12.1967 (56) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
2019 08.07.2020 | 2020 04.07.2021 | 2021 29.06.2022 | 2022 05.07.2023 | |
---|---|---|---|---|
Total Revenue | 237 701 € | 260 914 € | 299 686 € | 361 919 € |
Net profit (loss) for the period | 24 507 € | 37 091 € | 24 770 € | 45 433 € |
Profit Margin | 10% | 14% | 8% | 13% |
Current Assets | 104 603 € | 140 417 € | 166 570 € | 215 407 € |
Fixed Assets | 2 219 € | 5 942 € | 3 961 € | 2 047 € |
Total Assets | 106 822 € | 146 359 € | 170 531 € | 217 454 € |
Current Liabilities | 11 846 € | 14 292 € | 13 694 € | 15 184 € |
Non Current Liabilities | 0 € | 0 € | 0 € | 0 € |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | 94 976 € | 132 067 € | 156 837 € | 202 270 € |
Employees | 6 | 6 | 7 | 7 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 20 055.45 € | 20 982.28 € | 8 |
2023 Q4 | - | 20 669.36 € | 21 844 € | 9 |
2023 Q3 | - | 19 502.48 € | 20 689.92 € | 9 |
2023 Q2 | - | 15 758.3 € | 16 711.35 € | 10 |
2023 Q1 | - | 16 914.78 € | 17 843.38 € | 10 |
2022 Q4 | - | 15 909.22 € | 16 803.19 € | 8 |
2022 Q3 | - | 15 416.93 € | 16 371.18 € | 7 |
2022 Q2 | - | 13 282.27 € | 14 061.02 € | 11 |
2022 Q1 | - | 18 217.63 € | 19 320.41 € | 10 |
2021 Q4 | - | 13 343.85 € | 14 165.4 € | 10 |
2021 Q3 | - | 12 873.09 € | 13 752.73 € | 9 |
2021 Q2 | - | 11 840.36 € | 12 638.76 € | 8 |
2021 Q1 | - | 16 295.83 € | 17 433.44 € | 8 |
2020 Q4 | - | 13 858.48 € | 14 783.14 € | 10 |
2020 Q3 | - | 11 472.44 € | 12 182.56 € | 9 |
2020 Q2 | - | 9 847.2 € | 10 424.51 € | 9 |
2020 Q1 | - | 11 305.86 € | 11 981.81 € | 9 |